Market cap
$1.327 B
$8.87 +1.72%
Close of 22 Sept 2026
Revenue
—
Not reported
Earnings
—
Not reported
Shares outstanding
134,071,432
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap
All 160 →What if Immatics were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Immatics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.